SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Ruhstaller Thomas)
 

Sökning: WFRF:(Ruhstaller Thomas) > Predicting mortalit...

  • Gargiulo, PieraSwiss Grp Clin Canc Res SAKK Coordinating Ctr, Effingerstr 33, CH-3008 Bern, Switzerland (författare)

Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial : the APC-SAKK risk scores

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • 2019-01-02
  • SAGE PUBLICATIONS LTD,2019
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-393016
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393016URI
  • https://doi.org/10.1177/1758835918818351DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background: The prognosis of advanced pancreatic cancer (APC) is poor and differs considerably among patients. Therefore, it is clinically relevant to identify patients with APC who are more likely to benefit from palliative chemotherapy with reduced risk of toxicity. To date, there is no prognostic score universally recommended to help clinicians in planning the therapeutic management. Methods: Using individual patient data from 319 cases of APC treated with gemcitabine-based chemotherapy and enrolled in the SAKK 44/00-CECOG/PAN.1.3.001 randomized trial, several baseline variables, including inflammatory markers, were analysed post hoc as predictors of mortality and/or grade 3 or 4 chemotherapy-related toxicity and separate risk scores were developed. Results: Median survival of the study patients was 7.9 months (interquartile range 3.7-13.3 months). Independent predictors of mortality included increased Aspartate transaminase (ASAT), low performance status, increased derived neutrophil to lymphocyte ratio, increased Carbohydrate Antigen 19-9 (CA 19-9), low haemoglobin, presence of pain, presence of metastasis and increased alkaline phosphatase (ALP). During the study, 117 patients experienced at least one grade 3 or 4 adverse event. Independent predictors of toxicity included white blood cells, ALP, renal function and bilirubin levels at baseline. Both models displayed moderate levels of discrimination (C-statistic 0.68 and 0.64 for mortality and toxicity, respectively) and adequate calibration. Conclusions: We developed simple-to-use prognostic scores for mortality and severe toxicity for patients with APC. These scores can be useful in daily practice to identify patients with increased risk of death or toxicity and to plan the most appropriate therapeutic strategy to improve survival and quality of life. Further prospective studies to validate such scores are needed.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Dietrich, DanielSwiss Grp Clin Canc Res SAKK Coordinating Ctr, Effingerstr 33, CH-3008 Bern, Switzerland (författare)
  • Herrmann, RichardUniv Hosp, Basel, Switzerland (författare)
  • Bodoky, GyorgySzt Laszlo Teaching Hosp, Budapest, Hungary (författare)
  • Ruhstaller, ThomasKantonsspital, St Gallen, Switzerland (författare)
  • Scheithauer, WernerUniv Vienna, Med Sch, Vienna, Austria (författare)
  • Glimelius, BengtUppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)bengglim (författare)
  • Berardi, SimonaSwiss Grp Clin Canc Res SAKK Coordinating Ctr, Effingerstr 33, CH-3008 Bern, Switzerland (författare)
  • Pignata, SandroFdn G Pascale, Ist Nazl Tumori, Dept Urol & Gynecol, Naples, Italy (författare)
  • Brauchli, PeterSwiss Grp Clin Canc Res SAKK Coordinating Ctr, Effingerstr 33, CH-3008 Bern, Switzerland (författare)
  • Swiss Grp Clin Canc Res SAKK Coordinating Ctr, Effingerstr 33, CH-3008 Bern, SwitzerlandUniv Hosp, Basel, Switzerland (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY: SAGE PUBLICATIONS LTD111758-83401758-8359

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy